Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers

BACKGROUND: Immune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA) show good responses to frontline steroids. About two-third of cases relapse and require second-line treatment, including rituximab, mainly effective in AIHA, and thrombopoietin-receptor agonists (TPO-RAs) in ITP, while...

Descripción completa

Detalles Bibliográficos
Autores principales: Fattizzo, Bruno, Cantoni, Silvia, Giannotta, Juri Alessandro, Bandiera, Laura, Zavaglia, Rachele, Bortolotti, Marta, Barcellini, Wilma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109490/
https://www.ncbi.nlm.nih.gov/pubmed/35585968
http://dx.doi.org/10.1177/20406207221097780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109490/
https://www.ncbi.nlm.nih.gov/pubmed/35585968
http://dx.doi.org/10.1177/20406207221097780

Ejemplares similares